Ipamorelin
Selective GH secretagogue (pentapeptide)Studied in: selective growth-hormone release models.
← Catalog · Research overview
Sermorelin research overview
Sermorelin is a synthetic peptide matching the first 29 amino acids of natural GHRH, the shortest fully active portion of the hormone.
- CLASS
- GHRH (1–29) analog
- FORM
- Lyophilized powder
- TESTING
- HPLC purity and mass-spec identity by an independent lab — COA published per batch
- STORAGE
- −20 °C, dry, protected from light
What it is
Sermorelin is a synthetic peptide matching the first 29 amino acids of natural GHRH, the shortest fully active portion of the hormone.
What researchers have studied
Sermorelin has been explored in pituitary growth-hormone signaling. Published research includes:
- Pituitary GH release in laboratory and clinical-pharmacology literature
- GH-axis signaling and feedback research
- Age-related changes in GH secretion
GH Axis research
Peptides that act on the growth-hormone signaling pathway, studied for how they influence GH release in laboratory models.
This page summarizes published laboratory and animal (preclinical) research for educational purposes. It is not a claim of safety or effectiveness in humans. Sermorelin from Nova Peptide Solutions will be sold strictly for in-vitro laboratory research. Not evaluated by the FDA. Not for human or animal consumption, and not intended to diagnose, treat, cure or prevent any disease.
Related research compounds
CJC-1295
GHRH analogStudied in: growth-hormone-releasing-hormone signaling.